The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 338:221-225 January 22, 1998 Number 4
NextNext

Transplantation of Kidneys from Donors Whose Hearts Have Stopped Beating
Yong W. Cho, Ph.D., Paul I. Terasaki, Ph.D., J. Michael Cecka, Ph.D., and David W. Gjertson, Ph.D.

 

This Article
-Abstract
- PDF

Commentary
-Letters
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Attempts have recently been made to expand the number of cadaveric kidneys available for transplantation by using kidneys from donors without heartbeats in addition to those from brain-dead donors with beating hearts. We studied the efficacy of transplanting kidneys from donors without heartbeats on the basis of aggregate results from the Kidney Transplant Registry of the United Network for Organ Sharing.

Methods We compared the early function and survival rates of 229 kidney grafts from donors without heartbeats with those of 8718 grafts from cadaveric donors with heartbeats. All transplantations were performed at 64 U.S. transplantation centers. Cox proportional-hazards analysis was used to evaluate 10 major risk factors for graft failure.

Results The survival rate at one year was 83 percent for kidney grafts from donors without heartbeats, as compared with 86 percent for grafts from donors with heartbeats (P = 0.26). Among the kidneys from donors without heartbeats, the survival rate at one year was 89 percent for grafts from donors who had died of trauma, as compared with 78 percent for grafts from donors who had died of other causes (P = 0.04). The survival rates were high for grafts from donors without heartbeats despite the poorer early function of these grafts; 48 percent of the recipients required dialysis within the first week after transplantation, as compared with 22 percent of the recipients of grafts from donors with heartbeats. The primary-failure rate for kidneys from donors without heartbeats was 4 percent, as compared with 1 percent for kidneys from donors with heartbeats.

Conclusions Transplantation of kidneys from donors whose hearts have stopped beating, especially those who have died of trauma, is often successful, and the use of kidneys from such donors could increase the overall supply of cadaveric kidney transplants.


At the end of 1996, more than 34,000 patients undergoing dialysis were on the national waiting list for kidney transplants, but only about 8600 cadaveric kidneys were transplanted in that year.1 The number of patients awaiting cadaveric kidneys has increased progressively in recent years, and by the year 2000, more than 42,000 patients will be on the waiting list. Aside from the social costs of an inadequate supply of kidney transplants, the inability to treat patients optimally is frustrating for both the patients and the physicians who perform transplantation.

Use of kidneys from donors whose hearts have stopped beating could increase the supply of kidney transplants by a factor of 2 to 4.5.2 Currently, more than 99 percent of cadaveric kidneys available for transplantation come from donors whose hearts are beating but who are brain-dead and in the hospital. Most of the early kidney transplantations, performed during the 1960s, used kidneys from donors whose hearts had stopped beating.3,4 Under some circumstances, such kidneys can withstand warm ischemia for up to one hour,5,6 and kidneys removed from patients after their hearts have stopped beating can function well.7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22 To determine the efficacy of transplanting kidneys from donors without heartbeats, we compared 229 transplants from such donors with 8718 transplants from cadaveric donors with beating hearts.

Methods

Study Population

Since 1994, the United Network for Organ Sharing (UNOS) has collected information from organ-procurement organizations on cadaveric organs procured from donors without heartbeats in whom life support was withdrawn after family members had given consent for donation. Transplantation centers that accept kidneys from donors without heartbeats notify UNOS of their willingness to do so, and kidneys from such donors are allocated according to the same point system used to distribute kidneys from brain-dead donors with heartbeats.

From 1994 to 1996, a total of 229 kidneys from donors without heartbeats were collected by 30 of the 63 U.S. organ-procurement organizations (range, 1 to 38 kidneys per organization) and transplanted at the 64 U.S. transplantation centers (range, 1 to 31 kidney transplantations per center) that accepted kidneys from donors without heartbeats. A total of 8718 cadaveric kidneys from donors with heartbeats were transplanted by the same 64 centers during the same period. The graft-survival rates at the 64 centers did not differ significantly from those at the 186 centers that did not accept kidneys from donors without heartbeats. The analysis included follow-up information provided on UNOS survey forms at scheduled intervals after transplantation and received at the UNOS Kidney Transplant Registry through June 1997.

Statistical Analysis

Graft-survival rates were estimated with the use of the Kaplan–Meier product-limit method. The log-rank test was used to evaluate differences in the survival curves for the two groups of grafts. The death of a recipient was documented as a graft failure. The Wilcoxon rank-sum test was used to compare continuous variables, and the chi-square test was used to compare categorical variables. Variables that significantly influenced graft failure in univariate analyses were included (along with the dichotomous variable for the presence or absence of a heartbeat in the donor) in a multivariate Cox regression analysis. Less than 5 percent of values were missing for any covariate. Missing data for this analysis were replaced with modal values for categorical variables and mean values for continuous variables. In addition, continuous variables such as age, weight, cold-ischemia time, and the peak value for panel-reactive antibodies were categorized, since their effects on the hazard function were nonlinear. Plots of log[-log(survival function)] against time were used to check the validity of the proportionality assumption in the Cox model. Since the curves were parallel, this assumption was judged to be appropriate. Relative risks and their 95 percent confidence intervals were calculated with the use of the estimated regression coefficients and their standard errors in the Cox regression analysis. All statistical tests were two-tailed.

Results

The characteristics of the recipients and the donors are shown in Table 1. The proportions of female and white patients were significantly higher in the group receiving grafts from donors without heartbeats than in the group receiving grafts from donors with heartbeats. For donors without heartbeats, the average warm-ischemia time associated with the procurement surgery was 14 minutes, whereas for donors with heartbeats, there was no record of warm-ischemia time because it was close to 0 minutes. The second warm-ischemia time, or the time required to restore circulation in the recipient, was only three minutes longer for the recipients of kidneys from donors without heartbeats than for the recipients of kidneys from donors with heartbeats. Pump perfusion was used more frequently for kidneys from donors without heartbeats (50 percent vs. 20 percent).

View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of Renal-Transplant Recipients, Donors, and Renal Grafts.

 
The outcome of transplantation in the two groups of recipients is shown in Table 2. Anuria occurred on the first day in 11 percent of grafts from donors with heartbeats, as compared with 21 percent of grafts from donors without heartbeats (P<0.001). Twenty-two percent of the recipients of kidneys from donors with heartbeats required dialysis during the first week after transplantation, as compared with 48 percent of the recipients of kidneys from donors without heartbeats. The less-than-optimal state of the kidneys from donors without heartbeats was reflected in the proportion of recipients with high serum creatinine concentrations at the time of discharge. Primary graft failure (defined as a graft that never functioned) was reported in 4 percent of the recipients of kidneys from donors without heartbeats, as compared with 1 percent of the recipients of kidneys from donors with heartbeats.

View this table:
[in this window]
[in a new window]
 
Table 2. Early Function of Kidney Grafts from Donors without Heartbeats and Donors with Heartbeats.

 
The graft-survival rate at one year for kidneys from donors without heartbeats was 83 percent, as compared with 86 percent for kidneys from donors with heartbeats (P = 0.26) (Figure 1). The difference of three percentage points occurred within the first month, suggesting that it was due to a difference in ischemic damage. There were no longer-term consequences of ischemia; the loss rate between one month and one year was the same for the two groups of kidneys. Five recipients of kidneys from donors without heartbeats (2 percent) and 312 recipients of kidneys from donors with heartbeats (4 percent) died with functioning grafts during the study period. Less than 1 percent of patients were lost to follow-up during the study period (1 who received a kidney from a donor without a heartbeat and 72 who received kidneys from donors with heartbeats). One year after transplantation, the mean (±SD) serum creatinine concentration in the patients with functioning grafts was 1.9±0.9 mg per deciliter (170±80 µmol per liter) in the 91 recipients of kidneys from donors without heartbeats and 1.8±0.8 mg per deciliter (160±70 µmol per liter) in the 3598 recipients of kidneys from donors with heartbeats.


View larger version (3K):
[in this window]
[in a new window]
 
Figure 1. Graft-Survival Rates for Kidney Transplants from Donors with Heartbeats and Donors without Heartbeats.

Data are from the United Network for Organ Sharing for the period from 1994 to 1996.

 
The graft-survival rate at one year for kidneys from donors without heartbeats who had died of trauma was 89 percent, as compared with 78 percent for kidneys from donors without heartbeats who had died of other causes (P = 0.04) (Figure 2). We considered the possibility that this effect might be the result of the younger age of donors who had died of trauma, but when the analysis was stratified according to the donor's age, the cause of death was still correlated with the graft-survival rate. The survival of grafts from donors without heartbeats who had died of trauma was similar to that of grafts from donors with heartbeats. Survival was significantly poorer for kidneys from donors without heartbeats who had died of other causes (P = 0.02). However, the survival of grafts from donors without heartbeats who had died of nontraumatic causes did not differ significantly from the survival of grafts from donors with heartbeats who had died of similar causes (P = 0.23, data not shown).


View larger version (3K):
[in this window]
[in a new window]
 
Figure 2. Graft-Survival Rates for Kidney Transplants from Donors with Heartbeats and Donors without Heartbeats, According to the Cause of Death in the Donors without Heartbeats.

P = 0.02 for the comparison between donors with heartbeats and those without heartbeats who died from causes other than trauma. P = 0.04 for the comparison between donors without heartbeats who died from trauma and those without heartbeats who died from other causes.

 
Multivariate regression analysis of 10 potential risk factors showed that all factors except the presence or absence of a heartbeat in the donor were significantly associated with the risk of graft failure, after adjustment for the remaining factors (Table 3). In view of the effect of all the listed factors on graft survival, the difference between kidneys from donors without heartbeats and those from donors with heartbeats was small.

View this table:
[in this window]
[in a new window]
 
Table 3. Risk Factors for Graft Failure According to the Regression Analysis.

 
Discussion

Although the initial experience in transplanting kidneys from donors without heartbeats was in the United States,3,4 much of the recent experience has been in Europe,6,7,9,10,11,15,16,18,20,21 led by the Netherlands15 and Japan,8,12,19,22 where kidneys from cadaveric donors with heartbeats have been difficult to obtain. Interest in the use of grafts from donors without heartbeats has increased in the United States recently, with several encouraging studies.13,14,16,17 Our study of the results of 229 transplantations performed at 64 centers in the United States largely confirms the previous reports from single centers.

The most important finding of our study was that the survival of kidney grafts from donors without heartbeats was similar to that of grafts from donors with heartbeats. One year after transplantation, the kidneys from donors without heartbeats functioned well (as indicated by the mean serum creatinine concentration), suggesting that long-term survival rates for these kidneys will be similar to those for kidneys from donors with heartbeats, despite the poorer early function of the grafts from donors without heartbeats. Kidneys from donors without heartbeats who had died of trauma survived as well as those from donors with heartbeats. We do not know whether the small difference in survival associated with the cause of death in the donors without heartbeats reflects differences in their care before their hearts stopped beating.

In the early period after transplantation, kidneys from donors without heartbeats did not function as well as those from donors with heartbeats, a finding reported in several previous studies.2,6,8,9,12,14,15 Nearly half the recipients of kidneys from donors without heartbeats required dialysis during the first week after transplantation, and 4 percent of the kidneys in this group never functioned. The survival curves show that the difference between the survival of kidneys from donors without heartbeats and the survival of those from donors with heartbeats was entirely due to graft failure in the first month after transplantation. This means that the disadvantage of using kidneys from donors without heartbeats could be reduced considerably or eliminated if a kidney-viability test were available to exclude poor kidneys, particularly those that will never function. Several such tests have been developed: the tetrazolium test, which measures the metabolic activity of tubules either by visual timing of the color change23 or by spectrometric measurement,24 proton magnetic resonance spectroscopy,25 and measurement of alpha glutathione S-transferase activity.26 However, none of those tests have yet been validated for the purpose of documenting the viability of human kidneys.

The number of patients waiting for cadaveric kidney transplants has increased by about 2400 per year since 1988. If 2400 more kidneys from 1200 donors without heartbeats could have been procured each year, the waiting list would not have increased. Even today, the waiting list would not increase if each of the 63 organ-procurement agencies in the United States obtained kidneys from two donors without heartbeats each month. A program for procuring kidneys from donors without heartbeats has been reported to result in a 40 percent increase in the overall supply of cadaveric kidneys,2 and there may be twice as many donors without heartbeats as donors with heartbeats. A 40 percent increase in the supply of cadaveric kidneys in the United States would mean that there would be 3440 more kidneys available for transplantation than in 1995, an increase that (if maintained) might begin to reduce the number of patients on the waiting list for cadaveric kidney transplants each year.

In conclusion, the early results from 64 U.S. centers suggest that graft survival at one year is not adversely affected by transplanting kidneys from donors whose hearts have stopped beating. The supply of cadaveric grafts could be increased by using kidneys from these donors.

Supported in part through a subcontract with the United Network for Organ Sharing. The opinions expressed in this article are those of the authors and are not necessarily approved or endorsed by the network.


Source Information

From the Department of Surgery, University of California at Los Angeles School of Medicine, Los Angeles.

Address reprint requests to Dr. Cho at the UCLA Tissue Typing Laboratory, 950 Veteran Ave., Los Angeles, CA 90095-1652.

References

  1. United Network for Organ Sharing 1997 annual report of the US Scientific Registry for Transplant Recipients and the Organ and Transplantation Network. Richmond, Va.: UNOS, 1997. 
  2. Kootstra G. The asystolic, or non-heartbeating, donor. Transplantation 1997;63:917-921. [CrossRef][Medline]
  3. Hume DM, Magee JH, Kauffman HM Jr, Rittenbury MS, Prout GR Jr. Renal homotransplantation in man in modified recipients. Ann Surg 1963;158:608-644. [Medline]
  4. Starzl TE, Marchioro TL, Brittain RS, Holmes JH, Waddell WR. Problems in renal homotransplantation. JAMA 1964;187:734-740. [Medline]
  5. Anaise D, Smith R, Ishimaru M, et al. An approach to organ salvage from non-heartbeating cadaver donors under existing legal and ethical requirements for transplantation. Transplantation 1990;49:290-294. [Medline]
  6. Rigotti P, Morpurgo E, Comandella MG, et al. Non-heart-beating donors: an alternative organ source in kidney transplantation. Transplant Proc 1991;23:2579-2580. [Medline]
  7. Kootstra G, Wijnen R, van Hooff JP, van der Linden CJ. Twenty percent more kidneys through a non-heart beating program. Transplant Proc 1991;23:910-911. [Medline]
  8. Kozaki M, Matsuno N, Tamaki T, et al. Procurement of kidney grafts from non-heart-beating donors. Transplant Proc 1991;23:2575-2578. [Medline]
  9. Castelao AM, Grino JM, Gonzalez C, et al. Update of our experience in long-term renal function of kidneys transplanted from non-heart-beating cadaver donors. Transplant Proc 1993;25:1513-1515. [Medline]
  10. Wynen RMH, Booster M, Speatgens C, et al. Long-term follow-up of transplanted non-heart-beating donor kidneys: preliminary results of a retrospective study. Transplant Proc 1993;25:1522-1523. [Medline]
  11. Guillard G, Rat P, Haas O, Letourneau B, Isnardon JP, Favre JP. Renal harvesting after in situ cooling by intra-aortic double-balloon catheter. Transplant Proc 1993;25:1505-1506. [Medline]
  12. Matsuno N, Kozaki M, Sakurai E, et al. Effect of combination in situ cooling and machine perfusion preservation on non-heart-beating donor kidney procurement. Transplant Proc 1993;25:1516-1517. [Medline]
  13. Orloff MS, Reed AI, Erturk E, et al. Nonheartbeating cadaveric organ donation. Ann Surg 1994;220:578-583. [Medline]
  14. Casavilla A, Ramirez C, Shapiro R, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995;59:197-203. [Medline]
  15. Wijnen RMH, Booster MH, Stubenitsky BM, de Boer J, Heineman E, Kootstra G. Outcome of transplantation of non-heart-beating donor kidneys. Lancet 1995;345:1067-1070. [CrossRef][Medline]
  16. D'Alessandro AM, Hoffmann RM, Belzer FO. Non-heart-beating donors: one response to the organ shortage. Transplant Rev 1995;9:168-176. 
  17. D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al. Controlled non-heart-beating donors: a potential source of extrarenal organs. Transplant Proc 1995;27:707-709. [Medline]
  18. Schlumpf R, Weber M, Weinreich T, Spahn D, Rothlin M, Candinas D. Transplantation of kidneys from non-heart-beating donors: protocol, cardiac death diagnosis, and results. Transplant Proc 1996;28:107-109. [Medline]
  19. Hoshinaga K, Fujita T, Naide Y, et al. Early prognosis of 263 renal allografts harvested from non-heart-beating cadavers using an in situ cooling technique. Transplant Proc 1995;27:703-706. [Medline]
  20. Alonso A, Buitron JG, Gomez M, et al. Short- and long-term results with kidneys from non-heart-beating donors. Transplant Proc 1997;29:1378-1380. [CrossRef][Medline]
  21. Nicholson ML, Horsburgh T, Doughman TM, et al. Comparison of the results of renal transplants from conventional and non-heart-beating cadaveric donors. Transplant Proc 1997;29:1386-1387. [Medline]
  22. Shiroki R, Hoshinaga K, Horiba M, et al. Favorable prognosis of kidney allografts from unconditioned cadaveric donors whose procurement was initiated after cardiac arrest. Transplant Proc 1997;29:1388-1389. [Medline]
  23. Terasaki PI, Martin DC, Smith RB. A rapid metabolism test to screen cadaver kidneys for transplantation. Transplantation 1967;5:76-78.
  24. Yin L, Terasaki PI. A rapid quantitated viability test for transplant kidneys -- ready for human trial. Clin Transplant 1988;2:295-298.
  25. Hauet T, Mothes D, Goujon JM, et al. Assessment of functional activity of cold-stored kidney transplant by proton magnetic resonance spectroscopy. Transplant Proc 1996;28:2896-2898. [Medline]
  26. Kievit JK, Oomen APA, Janssen MA, van Kreel BK, Heineman E, Kootstra G. Viability assessment of non-heart-beating donor kidneys by alpha glutathione S-transferase in the machine perfusate. Transplant Proc 1997;29:1381-1383. [Medline]

 

This Article
-Abstract
- PDF

Commentary
-Letters
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation

Related Letters:

Analgesic Nephropathy
Michielsen P., De Schepper P., Baumeister M., Aicher B., Fox J. M., Thurlow W., De Broe M. E., Elseviers M. M.
Extract | Full Text  
N Engl J Med 1998; 339:48-50, Jul 2, 1998. Correspondence

Organs for Transplantation
Lopez-Navidad A., Caballero F., Bartlett S. T., Oldach D., Schimpff S. C., Selby R., Genyk Y., Jabbour N., Hilbrands L. B., Hordijk W., van der Vliet J. A., Remuzzi G., Gridelli B., Kahn J., Matas A.
Extract | Full Text  
N Engl J Med 2000; 343:1730-1732, Dec 7, 2000. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.